글로벌 혈관 확장제 시장 - 2030년까지의 산업 동향 및 예측

혈관 확장제 시장 분석 및 규모

혈관 확장제는 고혈압 치료의 핵심 요소입니다 . 혈관 확장제는 혈관을 이완하고 확장하여 혈류 저항을 줄여 혈압을 낮추는 데 도움이 됩니다. 고혈압은 심혈관 질환의 흔하고 중요한 위험 요소이므로 혈압 관리가 공중 보건에 필수적입니다.

Data Bridge Market Research는 2022년에 6,300.00백만 달러였던 혈관 확장제 시장이 2030년까지 10,041.24백만 달러에 도달할 것으로 예상되며, 2023-2030년 예측 기간 동안 6.0%의 CAGR을 보일 것으로 분석했습니다. "동맥 확장제"는 고혈압 유병률 증가로 인해 혈관 확장제 시장의 유형 세그먼트를 지배하고 있습니다. 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

보고 범위 및 시장 세분화

Market Definition

Vasodilators encompass a wide range of drugs and compounds used to manage various cardiovascular and vascular conditions. The market's size is significant due to the prevalence of conditions such as hypertension, heart disease, and peripheral vascular diseases worldwide.

Vasodilators are the class of therapeutics that causes vasodilation which means widen the blood vessels so that blood flows more easily through the blood vessels. Vasodilators help in the treatment of cardiovascular disorders such as high blood pressure and congestive heart failure.  It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period.

Global Vasodilators Market Dynamics

Drivers

• Rising Prevalence of Hypertension and Cardiovascular Diseases

Hypertension (high blood pressure) and cardiovascular diseases are among the leading causes of morbidity and mortality worldwide. Vasodilators are commonly used to manage these conditions by lowering blood pressure and improving blood flow. As these diseases continue to affect a significant portion of the global population, the demand for vasodilators remains high.

• Increased Awareness and Diagnosis

Increased awareness of cardiovascular risk factors and the importance of early diagnosis have led to more individuals seeking medical care and being diagnosed with hypertension and cardiovascular diseases. As a result, more patients are prescribed vasodilators, driving market growth.

Opportunity

• Government Initiatives and Healthcare Policies

Government healthcare policies and initiatives aimed at reducing the burden of cardiovascular diseases and improving public health may involve subsidies, funding for research, and support for the use of vasodilators. These policies can boost the market.

Restraints/Challenges

• Complex Treatment Regimens

Vasodilators are often used in combination with other medications, such as diuretics and beta-blockers, to optimize treatment. Complex treatment regimens can be challenging for patients to follow, leading to difficulties in medication adherence.

Recent Development

• In December 2021, Bayer AG announced that the company had received a product designation from the FDA (Food and Drug Administration) for artificial intelligence technology for Chronic Thromboembolic Pulmonary Hypertension (CTPH) Pattern Recognition.

Global Vasodilators Market Scope

The Vasodilators market is segmented on the basis of type, drugs, indication, route of administration, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Arterial Dilators
• Venous Dilators
• Mixed Dilators

Drugs

• Nitroglycerin
• Alprostadil
• Minoxidil
• Sorbitrate
• Others

Indication

• Hypertension
• Angina
• Heart Failure
• Others

Route of Administration

• Oral
• Parenteral
• Others

End User

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Global Vasodilators Market Regional Analysis/Insights

The global vasodilators market is analyzed and market size insights and trends are provided by country, type, drugs, indication, route of administration, end user, and distribution channel as referenced above.

The countries covered in the global vasodilators market  report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the global vasodilators market because of the strong base of healthcare facilities, the presence of major players in the market, the extraordinary healthcare infrastructure, and the large pool of people having hypertension.

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote healthcare, the rising health awareness among the people and growing demand for advanced medical technology for cardiac diseases, the large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.  

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global vasodilators market  also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the global vasodilators market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on global the Vasodilators market.

Competitive Landscape and Vasodilators Market Share Analysis

혈관 확장제 시장 경쟁 구도는 경쟁자에 대한 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭 및 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 혈관 확장제 시장과 관련된 회사의 초점에만 관련이 있습니다.

혈관 확장제 시장에서 활동하는 주요 기업은 다음과 같습니다.

• Sun Pharmaceutical Industries Ltd(인도).
• Teva Pharmaceutical Industries Ltd(이스라엘)
• Amneal Pharmaceutical Inc (미국)
• 지두스 카딜라(인도)
• 마일런 NV(미국)
• Aurobindo Pharma(인도)
• Bausch Health(캐나다)
• Hercon Pharmaceuticals, LLC(미국)
• Dr. Reddy's Laboratories Ltd(인도)

SKU-53544